HarmoniaMentis
Welcome to HarmoniaMentis
This website is dedicated to providing healthcare professionals with up-to-date information on the management of epilepsy. This is a promotional website managed and funded by Angelini Pharma.
HarmoniaMentis
This promotional website is managed and funded by Angelini Pharma and is intended for UK and Ireland healthcare professionals only.
Resources vault
For materials designed to support healthcare professionals and their patients.
Clinical insights in epilepsy management
United Kingdom: ONTOZRY® (cenobamate) is indicated for the adjunctive treatment of focal–onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite treatment with at least 2 anti–epileptic medicinal products.1
Republic of Ireland: ONTOZRY® (cenobamate) is indicated for the adjunctive treatment of focal–onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti–epileptic medicinal products.1
1. ONTOZRY® Summary of Product Characteristics. United Kingdom and European Union.
MAT-UKI-0247-P | August 2025
